BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3528222)

  • 1. An enzyme immunoassay for quantitation of a type 2 pneumocyte-specific surfactant-associated antigen in bronchoalveolar lavage fluid.
    Kumar RK; Truscott JY; Lykke AW
    J Immunoassay; 1986; 7(3):151-68. PubMed ID: 3528222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an alveolyn-like protein associated with mouse type 2 pneumocytes using immunochemical methods.
    Kumar RK; Smith GJ; Truscott JY; Hristoforidis CP; Lykke AW
    Biochem Biophys Res Commun; 1986 Sep; 139(3):1135-41. PubMed ID: 3533070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 pneumocyte responses to cyclophosphamide-induced pulmonary injury: functional and morphological correlation.
    Kumar RK; Truscott JY; Rhodes GC; Lykke AW
    Br J Exp Pathol; 1988 Feb; 69(1):69-80. PubMed ID: 3348961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoperoxidase slide assay. A new method for the demonstration of surface antigens on bronchoalveolar lavage cells.
    Costabel U; Bross KJ; Matthys H
    Bull Eur Physiopathol Respir; 1985; 21(4):381-7. PubMed ID: 3899223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry of a human type I pneumocyte-associated protein in lung.
    Singh J; Singh G; Katyal SL; Wong-Chong ML; McCloskey CA; Gottron SA
    Microsc Res Tech; 1993 Dec; 26(5):357-65. PubMed ID: 8286781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoultrastructural study of surfactant system. Distribution of specific protein of surface active material in rabbit lung.
    Sueishi K; Tanaka K; Oda T
    Lab Invest; 1977 Aug; 37(2):136-42. PubMed ID: 329000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspergillus antigen detection in bronchoalveolar lavage fluid from patients with invasive aspergillosis and aspergillomas.
    Andrews CP; Weiner MH
    Am J Med; 1982 Sep; 73(3):372-80. PubMed ID: 7124764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR antigens on human macrophages from bronchoalveolar lavage fluid.
    Costabel U; Bross KJ; Andreesen R; Matthys H
    Thorax; 1986 Apr; 41(4):261-5. PubMed ID: 3461577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An enzyme-linked immunosorbent assay (ELISA) for quantification of mouse surfactant protein D (SP-D).
    Hansen S; Schmidt V; Steffensen MA; Jensen PH; Gjerstorff M; Thiel S; Holmskov U
    J Immunol Methods; 2008 Jan; 330(1-2):75-85. PubMed ID: 18078951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant protein A in bronchoalveolar lavage fluid.
    van de Graaf EA; Jansen HM; Lutter R; Alberts C; Kobesen J; de Vries IJ; Out TA
    J Lab Clin Med; 1992 Aug; 120(2):252-63. PubMed ID: 1500824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The appearance of specific IgG and IgA antibodies to Streptococcus pneumoniae in serum and lung lavage fluid of mice after the administration of different antigens. 2. IgG and IgA antibody detection after intraperitoneal, aerosol and oral immunization with Streptococcus pneumoniae].
    Schumann V; Tischner H; Noack K; Schröder R; Pohl WD
    Z Erkr Atmungsorgane; 1988; 171(1):75-81. PubMed ID: 2973690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children.
    Todd DA; Marsh MJ; George A; Henderson NG; Barr H; Sebastian S; Clark GT; Koster G; Clark HW; Postle AD
    Pediatr Crit Care Med; 2010 Jan; 11(1):82-91. PubMed ID: 19550365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carcinoembryonic antigen (CEA) in the bronchoalveolar lavage fluid from patients with lung cancer (author's transl)].
    Shiraki R; Kinoshita M; Wagai F; Watanabe H; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Apr; 20(4):398-402. PubMed ID: 7109365
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoembryonic antigen in bronchoalveolar lavage fluid.
    Lemarie C; Lavandier M; Renoux M; Renoux G
    N Engl J Med; 1980 Sep; 303(10):586-7. PubMed ID: 7402229
    [No Abstract]   [Full Text] [Related]  

  • 15. The kinetics of macrophage and surfactant replacement in hamster lung following bronchopulmonary lavage.
    Brightwell J; Ellender M; Newman GE; Phizackerley PJ
    J Pathol; 1979 Jul; 128(3):133-42. PubMed ID: 583160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Stachybotrys chartarum on surfactant convertase activity in juvenile mice.
    Mason CD; Rand TG; Oulton M; MacDonald J; Anthes M
    Toxicol Appl Pharmacol; 2001 Apr; 172(1):21-8. PubMed ID: 11264019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary surfactant and the immune system].
    Griese M
    Monatsschr Kinderheilkd; 1992 Jan; 140(1):57-61. PubMed ID: 1565109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of extracellular bactericidal factors in pulmonary host defense.
    Coonrod JD
    Semin Respir Infect; 1986 Jun; 1(2):118-29. PubMed ID: 3317603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid.
    Silver RM; Metcalf JF; LeRoy EC
    Arthritis Rheum; 1986 Apr; 29(4):525-31. PubMed ID: 3707630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of HTLV-III/LAV-specific IgG and antigen in bronchoalveolar lavage fluid from two patients with lymphocytic interstitial pneumonitis associated with AIDS-related complex.
    Resnick L; Pitchenik AE; Fisher E; Croney R
    Am J Med; 1987 Mar; 82(3):553-6. PubMed ID: 3644589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.